Latest News about MDMA/assisted therapy
Recent news which mentions MDMA/assisted therapy
Veterans Deserve Access To Life-Changing Psychedelics Therapy: A Vital Solution For PTSD And Healing
November 11, 2024
From Benzinga
From Benzinga
PharmAla Biotech To Supply LaNeo MDMA For Mt. Sinai Clinical Trial
October 21, 2024
From Benzinga
From Benzinga
Sam Altman's Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA
September 25, 2024
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy
September 11, 2024
From Benzinga
Drug Science Research Group And London College Team Up To Advance MDMA-Assisted Therapy
September 04, 2024
From Benzinga
Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD
August 29, 2024
From Benzinga
Lykos Therapeutics Strategic Reorganization Following FDA's Decision Rejecting MDMA For PTSD Treatment
August 16, 2024
Tickers
NEWS
From Benzinga
From Benzinga
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
August 07, 2024
Tickers
NEWS
From Benzinga
Art Installation Near White House Urges FDA To Approve MDMA-Assisted Therapy For Veterans As Decision Time Looms
July 29, 2024
Tickers
NEWS
From Benzinga
From Benzinga
Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment
January 04, 2024
From Benzinga
Could MDMA Revolutionize PTSD Treatment? In Historic Move, FDA Considers New Drug Application
December 12, 2023
From Benzinga
Canadian Practitioners Can Now Enroll In MDMA-Assisted Psychotherapy Training Program
September 25, 2023
From Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Tickers
NUMIF
From Benzinga
Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next
September 14, 2023
From Benzinga
From Benzinga
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
June 20, 2023
From Benzinga
Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study
June 16, 2023
From Benzinga
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
June 12, 2023
Tickers
PMBHF
From Benzinga
From Benzinga
Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies
April 11, 2023
Tickers
FLHLF
From Benzinga
From Benzinga
MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production
March 02, 2023
Tickers
AWKNF
From Benzinga
Australia's Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions
February 07, 2023
Tickers
NUMIF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
